imipramine has been researched along with Chromosome-Defective Micronuclei in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sołek, P | 1 |
Mytych, J | 1 |
Tabęcka-Łonczyńska, A | 1 |
Koziorowski, M | 1 |
Madrigal-Bujaidar, E | 1 |
Madrigal-Santillán, EO | 1 |
Alvarez-Gonzalez, I | 1 |
Baez, R | 1 |
Marquez, P | 1 |
2 other studies available for imipramine and Chromosome-Defective Micronuclei
Article | Year |
---|---|
Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Cell Line; Escitalopram; Fluoxe | 2021 |
Micronuclei induced by imipramine and desipramine in mice: a subchronic study.
Topics: Animals; Antidepressive Agents, Tricyclic; Bone Marrow Cells; Desipramine; Imipramine; Male; Mice; M | 2008 |